![]() |
||||||
|
![]() | Fusion Gene Summary |
![]() | Fusion Gene ORF analysis |
![]() | Fusion Genomic Features |
![]() | Fusion Protein Features |
![]() | Fusion Gene Sequence |
![]() | Fusion Gene PPI analysis |
![]() | Related Drugs |
![]() | Related Diseases |
Fusion gene:FANCA-CYP20A1 (FusionGDB2 ID:HG2175TG57404) |
Fusion Gene Summary for FANCA-CYP20A1 |
![]() |
Fusion gene information | Fusion gene name: FANCA-CYP20A1 | Fusion gene ID: hg2175tg57404 | Hgene | Tgene | Gene symbol | FANCA | CYP20A1 | Gene ID | 2175 | 57404 |
Gene name | FA complementation group A | cytochrome P450 family 20 subfamily A member 1 | |
Synonyms | FA|FA-H|FA1|FAA|FACA|FAH|FANCH | CYP-M | |
Cytomap | ('FANCA')('CYP20A1') 16q24.3 | 2q33.2 | |
Type of gene | protein-coding | protein-coding | |
Description | Fanconi anemia group A proteinFanconi anemia complementation group AFanconi anemia, complementation group HFanconi anemia, type 1 | cytochrome P450 20A1cytochrome P450 monooxygenasecytochrome P450, family 20, subfamily A, polypeptide 1 | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000389301, ENST00000389302, ENST00000534992, ENST00000543736, ENST00000563673, ENST00000568369, ENST00000567284, | ||
Fusion gene scores | * DoF score | 13 X 12 X 5=780 | 8 X 11 X 5=440 |
# samples | 13 | 9 | |
** MAII score | log2(13/780*10)=-2.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(9/440*10)=-2.28950661719499 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: FANCA [Title/Abstract] AND CYP20A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | FANCA(89880927)-CYP20A1(204143295), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. | FANCA-CYP20A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. FANCA-CYP20A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
![]() |
![]() * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | STAD | TCGA-R5-A7ZF | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
Top |
Fusion Gene ORF analysis for FANCA-CYP20A1 |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-3UTR | ENST00000389301 | ENST00000429815 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000389301 | ENST00000461371 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000389302 | ENST00000429815 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000389302 | ENST00000461371 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000534992 | ENST00000429815 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000534992 | ENST00000461371 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000543736 | ENST00000429815 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000543736 | ENST00000461371 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000563673 | ENST00000429815 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000563673 | ENST00000461371 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000568369 | ENST00000429815 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
5CDS-3UTR | ENST00000568369 | ENST00000461371 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
In-frame | ENST00000389301 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
In-frame | ENST00000389302 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
In-frame | ENST00000534992 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
In-frame | ENST00000543736 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
In-frame | ENST00000563673 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
In-frame | ENST00000568369 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
intron-3CDS | ENST00000567284 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
intron-3UTR | ENST00000567284 | ENST00000429815 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
intron-3UTR | ENST00000567284 | ENST00000461371 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000389301 | FANCA | chr16 | 89880927 | - | ENST00000356079 | CYP20A1 | chr2 | 204143295 | + | 1461 | 314 | 31 | 1023 | 330 |
ENST00000568369 | FANCA | chr16 | 89880927 | - | ENST00000356079 | CYP20A1 | chr2 | 204143295 | + | 1461 | 314 | 31 | 1023 | 330 |
ENST00000389302 | FANCA | chr16 | 89880927 | - | ENST00000356079 | CYP20A1 | chr2 | 204143295 | + | 1472 | 325 | 42 | 1034 | 330 |
ENST00000563673 | FANCA | chr16 | 89880927 | - | ENST00000356079 | CYP20A1 | chr2 | 204143295 | + | 1450 | 303 | 20 | 1012 | 330 |
ENST00000534992 | FANCA | chr16 | 89880927 | - | ENST00000356079 | CYP20A1 | chr2 | 204143295 | + | 1470 | 323 | 40 | 1032 | 330 |
ENST00000543736 | FANCA | chr16 | 89880927 | - | ENST00000356079 | CYP20A1 | chr2 | 204143295 | + | 1472 | 325 | 42 | 1034 | 330 |
![]() |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000389301 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 0.00017643 | 0.99982363 |
ENST00000568369 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 0.00017643 | 0.99982363 |
ENST00000389302 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 0.000175875 | 0.9998241 |
ENST00000563673 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 0.000173969 | 0.999826 |
ENST00000534992 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 0.000179191 | 0.9998209 |
ENST00000543736 | ENST00000356079 | FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 0.000175875 | 0.9998241 |
Top |
Fusion Genomic Features for FANCA-CYP20A1 |
![]() |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 1.40E-06 | 0.99999857 |
FANCA | chr16 | 89880927 | - | CYP20A1 | chr2 | 204143295 | + | 1.40E-06 | 0.99999857 |
![]() |
![]() |
![]() |
![]() |
Top |
Fusion Protein Features for FANCA-CYP20A1 |
![]() Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr16:89880927/chr2:204143295) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
![]() |
![]() |
Hgene | Tgene |
. | . |
FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | FANCA | chr16:89880927 | chr2:204143295 | ENST00000389301 | - | 3 | 43 | 18_34 | 94 | 1456.0 | Motif | Nuclear localization signal |
Hgene | FANCA | chr16:89880927 | chr2:204143295 | ENST00000389302 | - | 3 | 11 | 18_34 | 94 | 298.0 | Motif | Nuclear localization signal |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Tgene | CYP20A1 | chr16:89880927 | chr2:204143295 | ENST00000356079 | 5 | 13 | 4_24 | 226 | 463.0 | Transmembrane | Helical |
Top |
Fusion Gene Sequence for FANCA-CYP20A1 |
![]() |
>29303_29303_1_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000389301_CYP20A1_chr2_204143295_ENST00000356079_length(transcript)=1461nt_BP=314nt AGCCGCCGCCGGGGCTGTAGGCGCCAAGGCCATGTCCGACTCGTGGGTCCCGAACTCCGCCTCGGGCCAGGACCCAGGGGGCCGCCGGAG GGCCTGGGCCGAGCTGCTGGCGGGAAGGGTCAAGAGGGAAAAATATAATCCTGAAAGGGCACAGAAATTAAAGGAATCAGCTGTGCGCCT CCTGCGAAGCCATCAGGACCTGAATGCCCTTTTGCTTGAGGTAGAAGGTCCACTGTGTAAAAAATTGTCTCTCAGCAAAGTGATTGACTG TGACAGTTCTGAGGCCTATGCTAATCATTCTAGTTCATTTATAGCCCTCATGCAACTGGAGTCTGTTTTAAGGAACATCATAAAAGAACG AAAAGGAAGGAACTTCAGTCAACATATTTTCATTGACTCCTTAGTACAAGGGAACCTTAATGACCAACAGATCCTAGAAGACAGTATGAT ATTTTCTCTGGCCAGTTGCATAATAACTGCAAAATTGTGTACCTGGGCAATCTGTTTTTTAACCACCTCTGAAGAAGTTCAAAAAAAATT ATATGAAGAGATAAACCAAGTTTTTGGAAATGGTCCTGTTACTCCAGAGAAAATTGAGCAGCTCAGATATTGTCAGCATGTGCTTTGTGA AACTGTTCGAACTGCCAAACTGACTCCAGTTTCTGCCCAGCTTCAAGATATTGAAGGAAAAATTGACCGATTTATTATTCCTAGAGAGAC CCTCGTCCTTTATGCCCTTGGTGTGGTACTTCAGGATCCTAATACTTGGCCATCTCCACACAAGTTTGATCCAGATCGGTTTGATGATGA ATTAGTAATGAAAACTTTTTCCTCACTTGGATTCTCAGGCACACAGGAGTGTCCAGAGTTGAGGTTTGCATATATGGTGACCACAGTACT TCTTAGTGTATTGGTGAAGAGACTGCACCTACTTTCTGTGGAGGGACAGGTTATTGAAACAAAGTATGAACTGGTAACATCATCAAGGGA AGAAGCTTGGATCACTGTCTCAAAGAGATATTAAAATTTTATACATTTAAAATCATTGTTAAATTGATTGAGGAAAACAACCATTTAAAA AAAATCTATGTTGAATCCTTTTATAAACCAGTATCACTTTGTAATATAAACACCTATTTGTACTTAATTTTGTAAATTTGGATTTTTATA TATCATATTTTCTTAATTCATTGTACACATTTGACTTACTGCACAGTATATTGATCATTTTAATGGGAAACTTTAGCTTTCTACTTTTTA TTTTTGTTTTTTCACTTTCTATGCCATTATTTTTGTATTCTTTTTCTTAGTGTGAGCTCTAAAATCAATGTTCTTGAAAAAGAAATTATT TTGCAGAAGTTGGGGAATCATGTTTGTTGAATATGTATAAAATAGAAACATAGGCTGGGCGCGGTGGCTCACACCTGTAATCCCTACACT >29303_29303_1_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000389301_CYP20A1_chr2_204143295_ENST00000356079_length(amino acids)=330AA_BP=94 MSDSWVPNSASGQDPGGRRRAWAELLAGRVKREKYNPERAQKLKESAVRLLRSHQDLNALLLEVEGPLCKKLSLSKVIDCDSSEAYANHS SSFIALMQLESVLRNIIKERKGRNFSQHIFIDSLVQGNLNDQQILEDSMIFSLASCIITAKLCTWAICFLTTSEEVQKKLYEEINQVFGN GPVTPEKIEQLRYCQHVLCETVRTAKLTPVSAQLQDIEGKIDRFIIPRETLVLYALGVVLQDPNTWPSPHKFDPDRFDDELVMKTFSSLG -------------------------------------------------------------- >29303_29303_2_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000389302_CYP20A1_chr2_204143295_ENST00000356079_length(transcript)=1472nt_BP=325nt CGGGCGCAGGGAGCCGCCGCCGGGGCTGTAGGCGCCAAGGCCATGTCCGACTCGTGGGTCCCGAACTCCGCCTCGGGCCAGGACCCAGGG GGCCGCCGGAGGGCCTGGGCCGAGCTGCTGGCGGGAAGGGTCAAGAGGGAAAAATATAATCCTGAAAGGGCACAGAAATTAAAGGAATCA GCTGTGCGCCTCCTGCGAAGCCATCAGGACCTGAATGCCCTTTTGCTTGAGGTAGAAGGTCCACTGTGTAAAAAATTGTCTCTCAGCAAA GTGATTGACTGTGACAGTTCTGAGGCCTATGCTAATCATTCTAGTTCATTTATAGCCCTCATGCAACTGGAGTCTGTTTTAAGGAACATC ATAAAAGAACGAAAAGGAAGGAACTTCAGTCAACATATTTTCATTGACTCCTTAGTACAAGGGAACCTTAATGACCAACAGATCCTAGAA GACAGTATGATATTTTCTCTGGCCAGTTGCATAATAACTGCAAAATTGTGTACCTGGGCAATCTGTTTTTTAACCACCTCTGAAGAAGTT CAAAAAAAATTATATGAAGAGATAAACCAAGTTTTTGGAAATGGTCCTGTTACTCCAGAGAAAATTGAGCAGCTCAGATATTGTCAGCAT GTGCTTTGTGAAACTGTTCGAACTGCCAAACTGACTCCAGTTTCTGCCCAGCTTCAAGATATTGAAGGAAAAATTGACCGATTTATTATT CCTAGAGAGACCCTCGTCCTTTATGCCCTTGGTGTGGTACTTCAGGATCCTAATACTTGGCCATCTCCACACAAGTTTGATCCAGATCGG TTTGATGATGAATTAGTAATGAAAACTTTTTCCTCACTTGGATTCTCAGGCACACAGGAGTGTCCAGAGTTGAGGTTTGCATATATGGTG ACCACAGTACTTCTTAGTGTATTGGTGAAGAGACTGCACCTACTTTCTGTGGAGGGACAGGTTATTGAAACAAAGTATGAACTGGTAACA TCATCAAGGGAAGAAGCTTGGATCACTGTCTCAAAGAGATATTAAAATTTTATACATTTAAAATCATTGTTAAATTGATTGAGGAAAACA ACCATTTAAAAAAAATCTATGTTGAATCCTTTTATAAACCAGTATCACTTTGTAATATAAACACCTATTTGTACTTAATTTTGTAAATTT GGATTTTTATATATCATATTTTCTTAATTCATTGTACACATTTGACTTACTGCACAGTATATTGATCATTTTAATGGGAAACTTTAGCTT TCTACTTTTTATTTTTGTTTTTTCACTTTCTATGCCATTATTTTTGTATTCTTTTTCTTAGTGTGAGCTCTAAAATCAATGTTCTTGAAA AAGAAATTATTTTGCAGAAGTTGGGGAATCATGTTTGTTGAATATGTATAAAATAGAAACATAGGCTGGGCGCGGTGGCTCACACCTGTA >29303_29303_2_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000389302_CYP20A1_chr2_204143295_ENST00000356079_length(amino acids)=330AA_BP=94 MSDSWVPNSASGQDPGGRRRAWAELLAGRVKREKYNPERAQKLKESAVRLLRSHQDLNALLLEVEGPLCKKLSLSKVIDCDSSEAYANHS SSFIALMQLESVLRNIIKERKGRNFSQHIFIDSLVQGNLNDQQILEDSMIFSLASCIITAKLCTWAICFLTTSEEVQKKLYEEINQVFGN GPVTPEKIEQLRYCQHVLCETVRTAKLTPVSAQLQDIEGKIDRFIIPRETLVLYALGVVLQDPNTWPSPHKFDPDRFDDELVMKTFSSLG -------------------------------------------------------------- >29303_29303_3_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000534992_CYP20A1_chr2_204143295_ENST00000356079_length(transcript)=1470nt_BP=323nt GGCGCAGGGAGCCGCCGCCGGGGCTGTAGGCGCCAAGGCCATGTCCGACTCGTGGGTCCCGAACTCCGCCTCGGGCCAGGACCCAGGGGG CCGCCGGAGGGCCTGGGCCGAGCTGCTGGCGGGAAGGGTCAAGAGGGAAAAATATAATCCTGAAAGGGCACAGAAATTAAAGGAATCAGC TGTGCGCCTCCTGCGAAGCCATCAGGACCTGAATGCCCTTTTGCTTGAGGTAGAAGGTCCACTGTGTAAAAAATTGTCTCTCAGCAAAGT GATTGACTGTGACAGTTCTGAGGCCTATGCTAATCATTCTAGTTCATTTATAGCCCTCATGCAACTGGAGTCTGTTTTAAGGAACATCAT AAAAGAACGAAAAGGAAGGAACTTCAGTCAACATATTTTCATTGACTCCTTAGTACAAGGGAACCTTAATGACCAACAGATCCTAGAAGA CAGTATGATATTTTCTCTGGCCAGTTGCATAATAACTGCAAAATTGTGTACCTGGGCAATCTGTTTTTTAACCACCTCTGAAGAAGTTCA AAAAAAATTATATGAAGAGATAAACCAAGTTTTTGGAAATGGTCCTGTTACTCCAGAGAAAATTGAGCAGCTCAGATATTGTCAGCATGT GCTTTGTGAAACTGTTCGAACTGCCAAACTGACTCCAGTTTCTGCCCAGCTTCAAGATATTGAAGGAAAAATTGACCGATTTATTATTCC TAGAGAGACCCTCGTCCTTTATGCCCTTGGTGTGGTACTTCAGGATCCTAATACTTGGCCATCTCCACACAAGTTTGATCCAGATCGGTT TGATGATGAATTAGTAATGAAAACTTTTTCCTCACTTGGATTCTCAGGCACACAGGAGTGTCCAGAGTTGAGGTTTGCATATATGGTGAC CACAGTACTTCTTAGTGTATTGGTGAAGAGACTGCACCTACTTTCTGTGGAGGGACAGGTTATTGAAACAAAGTATGAACTGGTAACATC ATCAAGGGAAGAAGCTTGGATCACTGTCTCAAAGAGATATTAAAATTTTATACATTTAAAATCATTGTTAAATTGATTGAGGAAAACAAC CATTTAAAAAAAATCTATGTTGAATCCTTTTATAAACCAGTATCACTTTGTAATATAAACACCTATTTGTACTTAATTTTGTAAATTTGG ATTTTTATATATCATATTTTCTTAATTCATTGTACACATTTGACTTACTGCACAGTATATTGATCATTTTAATGGGAAACTTTAGCTTTC TACTTTTTATTTTTGTTTTTTCACTTTCTATGCCATTATTTTTGTATTCTTTTTCTTAGTGTGAGCTCTAAAATCAATGTTCTTGAAAAA GAAATTATTTTGCAGAAGTTGGGGAATCATGTTTGTTGAATATGTATAAAATAGAAACATAGGCTGGGCGCGGTGGCTCACACCTGTAAT >29303_29303_3_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000534992_CYP20A1_chr2_204143295_ENST00000356079_length(amino acids)=330AA_BP=94 MSDSWVPNSASGQDPGGRRRAWAELLAGRVKREKYNPERAQKLKESAVRLLRSHQDLNALLLEVEGPLCKKLSLSKVIDCDSSEAYANHS SSFIALMQLESVLRNIIKERKGRNFSQHIFIDSLVQGNLNDQQILEDSMIFSLASCIITAKLCTWAICFLTTSEEVQKKLYEEINQVFGN GPVTPEKIEQLRYCQHVLCETVRTAKLTPVSAQLQDIEGKIDRFIIPRETLVLYALGVVLQDPNTWPSPHKFDPDRFDDELVMKTFSSLG -------------------------------------------------------------- >29303_29303_4_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000543736_CYP20A1_chr2_204143295_ENST00000356079_length(transcript)=1472nt_BP=325nt CGGGCGCAGGGAGCCGCCGCCGGGGCTGTAGGCGCCAAGGCCATGTCCGACTCGTGGGTCCCGAACTCCGCCTCGGGCCAGGACCCAGGG GGCCGCCGGAGGGCCTGGGCCGAGCTGCTGGCGGGAAGGGTCAAGAGGGAAAAATATAATCCTGAAAGGGCACAGAAATTAAAGGAATCA GCTGTGCGCCTCCTGCGAAGCCATCAGGACCTGAATGCCCTTTTGCTTGAGGTAGAAGGTCCACTGTGTAAAAAATTGTCTCTCAGCAAA GTGATTGACTGTGACAGTTCTGAGGCCTATGCTAATCATTCTAGTTCATTTATAGCCCTCATGCAACTGGAGTCTGTTTTAAGGAACATC ATAAAAGAACGAAAAGGAAGGAACTTCAGTCAACATATTTTCATTGACTCCTTAGTACAAGGGAACCTTAATGACCAACAGATCCTAGAA GACAGTATGATATTTTCTCTGGCCAGTTGCATAATAACTGCAAAATTGTGTACCTGGGCAATCTGTTTTTTAACCACCTCTGAAGAAGTT CAAAAAAAATTATATGAAGAGATAAACCAAGTTTTTGGAAATGGTCCTGTTACTCCAGAGAAAATTGAGCAGCTCAGATATTGTCAGCAT GTGCTTTGTGAAACTGTTCGAACTGCCAAACTGACTCCAGTTTCTGCCCAGCTTCAAGATATTGAAGGAAAAATTGACCGATTTATTATT CCTAGAGAGACCCTCGTCCTTTATGCCCTTGGTGTGGTACTTCAGGATCCTAATACTTGGCCATCTCCACACAAGTTTGATCCAGATCGG TTTGATGATGAATTAGTAATGAAAACTTTTTCCTCACTTGGATTCTCAGGCACACAGGAGTGTCCAGAGTTGAGGTTTGCATATATGGTG ACCACAGTACTTCTTAGTGTATTGGTGAAGAGACTGCACCTACTTTCTGTGGAGGGACAGGTTATTGAAACAAAGTATGAACTGGTAACA TCATCAAGGGAAGAAGCTTGGATCACTGTCTCAAAGAGATATTAAAATTTTATACATTTAAAATCATTGTTAAATTGATTGAGGAAAACA ACCATTTAAAAAAAATCTATGTTGAATCCTTTTATAAACCAGTATCACTTTGTAATATAAACACCTATTTGTACTTAATTTTGTAAATTT GGATTTTTATATATCATATTTTCTTAATTCATTGTACACATTTGACTTACTGCACAGTATATTGATCATTTTAATGGGAAACTTTAGCTT TCTACTTTTTATTTTTGTTTTTTCACTTTCTATGCCATTATTTTTGTATTCTTTTTCTTAGTGTGAGCTCTAAAATCAATGTTCTTGAAA AAGAAATTATTTTGCAGAAGTTGGGGAATCATGTTTGTTGAATATGTATAAAATAGAAACATAGGCTGGGCGCGGTGGCTCACACCTGTA >29303_29303_4_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000543736_CYP20A1_chr2_204143295_ENST00000356079_length(amino acids)=330AA_BP=94 MSDSWVPNSASGQDPGGRRRAWAELLAGRVKREKYNPERAQKLKESAVRLLRSHQDLNALLLEVEGPLCKKLSLSKVIDCDSSEAYANHS SSFIALMQLESVLRNIIKERKGRNFSQHIFIDSLVQGNLNDQQILEDSMIFSLASCIITAKLCTWAICFLTTSEEVQKKLYEEINQVFGN GPVTPEKIEQLRYCQHVLCETVRTAKLTPVSAQLQDIEGKIDRFIIPRETLVLYALGVVLQDPNTWPSPHKFDPDRFDDELVMKTFSSLG -------------------------------------------------------------- >29303_29303_5_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000563673_CYP20A1_chr2_204143295_ENST00000356079_length(transcript)=1450nt_BP=303nt GGGCTGTAGGCGCCAAGGCCATGTCCGACTCGTGGGTCCCGAACTCCGCCTCGGGCCAGGACCCAGGGGGCCGCCGGAGGGCCTGGGCCG AGCTGCTGGCGGGAAGGGTCAAGAGGGAAAAATATAATCCTGAAAGGGCACAGAAATTAAAGGAATCAGCTGTGCGCCTCCTGCGAAGCC ATCAGGACCTGAATGCCCTTTTGCTTGAGGTAGAAGGTCCACTGTGTAAAAAATTGTCTCTCAGCAAAGTGATTGACTGTGACAGTTCTG AGGCCTATGCTAATCATTCTAGTTCATTTATAGCCCTCATGCAACTGGAGTCTGTTTTAAGGAACATCATAAAAGAACGAAAAGGAAGGA ACTTCAGTCAACATATTTTCATTGACTCCTTAGTACAAGGGAACCTTAATGACCAACAGATCCTAGAAGACAGTATGATATTTTCTCTGG CCAGTTGCATAATAACTGCAAAATTGTGTACCTGGGCAATCTGTTTTTTAACCACCTCTGAAGAAGTTCAAAAAAAATTATATGAAGAGA TAAACCAAGTTTTTGGAAATGGTCCTGTTACTCCAGAGAAAATTGAGCAGCTCAGATATTGTCAGCATGTGCTTTGTGAAACTGTTCGAA CTGCCAAACTGACTCCAGTTTCTGCCCAGCTTCAAGATATTGAAGGAAAAATTGACCGATTTATTATTCCTAGAGAGACCCTCGTCCTTT ATGCCCTTGGTGTGGTACTTCAGGATCCTAATACTTGGCCATCTCCACACAAGTTTGATCCAGATCGGTTTGATGATGAATTAGTAATGA AAACTTTTTCCTCACTTGGATTCTCAGGCACACAGGAGTGTCCAGAGTTGAGGTTTGCATATATGGTGACCACAGTACTTCTTAGTGTAT TGGTGAAGAGACTGCACCTACTTTCTGTGGAGGGACAGGTTATTGAAACAAAGTATGAACTGGTAACATCATCAAGGGAAGAAGCTTGGA TCACTGTCTCAAAGAGATATTAAAATTTTATACATTTAAAATCATTGTTAAATTGATTGAGGAAAACAACCATTTAAAAAAAATCTATGT TGAATCCTTTTATAAACCAGTATCACTTTGTAATATAAACACCTATTTGTACTTAATTTTGTAAATTTGGATTTTTATATATCATATTTT CTTAATTCATTGTACACATTTGACTTACTGCACAGTATATTGATCATTTTAATGGGAAACTTTAGCTTTCTACTTTTTATTTTTGTTTTT TCACTTTCTATGCCATTATTTTTGTATTCTTTTTCTTAGTGTGAGCTCTAAAATCAATGTTCTTGAAAAAGAAATTATTTTGCAGAAGTT GGGGAATCATGTTTGTTGAATATGTATAAAATAGAAACATAGGCTGGGCGCGGTGGCTCACACCTGTAATCCCTACACTTTGGGAGGCTG >29303_29303_5_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000563673_CYP20A1_chr2_204143295_ENST00000356079_length(amino acids)=330AA_BP=94 MSDSWVPNSASGQDPGGRRRAWAELLAGRVKREKYNPERAQKLKESAVRLLRSHQDLNALLLEVEGPLCKKLSLSKVIDCDSSEAYANHS SSFIALMQLESVLRNIIKERKGRNFSQHIFIDSLVQGNLNDQQILEDSMIFSLASCIITAKLCTWAICFLTTSEEVQKKLYEEINQVFGN GPVTPEKIEQLRYCQHVLCETVRTAKLTPVSAQLQDIEGKIDRFIIPRETLVLYALGVVLQDPNTWPSPHKFDPDRFDDELVMKTFSSLG -------------------------------------------------------------- >29303_29303_6_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000568369_CYP20A1_chr2_204143295_ENST00000356079_length(transcript)=1461nt_BP=314nt AGCCGCCGCCGGGGCTGTAGGCGCCAAGGCCATGTCCGACTCGTGGGTCCCGAACTCCGCCTCGGGCCAGGACCCAGGGGGCCGCCGGAG GGCCTGGGCCGAGCTGCTGGCGGGAAGGGTCAAGAGGGAAAAATATAATCCTGAAAGGGCACAGAAATTAAAGGAATCAGCTGTGCGCCT CCTGCGAAGCCATCAGGACCTGAATGCCCTTTTGCTTGAGGTAGAAGGTCCACTGTGTAAAAAATTGTCTCTCAGCAAAGTGATTGACTG TGACAGTTCTGAGGCCTATGCTAATCATTCTAGTTCATTTATAGCCCTCATGCAACTGGAGTCTGTTTTAAGGAACATCATAAAAGAACG AAAAGGAAGGAACTTCAGTCAACATATTTTCATTGACTCCTTAGTACAAGGGAACCTTAATGACCAACAGATCCTAGAAGACAGTATGAT ATTTTCTCTGGCCAGTTGCATAATAACTGCAAAATTGTGTACCTGGGCAATCTGTTTTTTAACCACCTCTGAAGAAGTTCAAAAAAAATT ATATGAAGAGATAAACCAAGTTTTTGGAAATGGTCCTGTTACTCCAGAGAAAATTGAGCAGCTCAGATATTGTCAGCATGTGCTTTGTGA AACTGTTCGAACTGCCAAACTGACTCCAGTTTCTGCCCAGCTTCAAGATATTGAAGGAAAAATTGACCGATTTATTATTCCTAGAGAGAC CCTCGTCCTTTATGCCCTTGGTGTGGTACTTCAGGATCCTAATACTTGGCCATCTCCACACAAGTTTGATCCAGATCGGTTTGATGATGA ATTAGTAATGAAAACTTTTTCCTCACTTGGATTCTCAGGCACACAGGAGTGTCCAGAGTTGAGGTTTGCATATATGGTGACCACAGTACT TCTTAGTGTATTGGTGAAGAGACTGCACCTACTTTCTGTGGAGGGACAGGTTATTGAAACAAAGTATGAACTGGTAACATCATCAAGGGA AGAAGCTTGGATCACTGTCTCAAAGAGATATTAAAATTTTATACATTTAAAATCATTGTTAAATTGATTGAGGAAAACAACCATTTAAAA AAAATCTATGTTGAATCCTTTTATAAACCAGTATCACTTTGTAATATAAACACCTATTTGTACTTAATTTTGTAAATTTGGATTTTTATA TATCATATTTTCTTAATTCATTGTACACATTTGACTTACTGCACAGTATATTGATCATTTTAATGGGAAACTTTAGCTTTCTACTTTTTA TTTTTGTTTTTTCACTTTCTATGCCATTATTTTTGTATTCTTTTTCTTAGTGTGAGCTCTAAAATCAATGTTCTTGAAAAAGAAATTATT TTGCAGAAGTTGGGGAATCATGTTTGTTGAATATGTATAAAATAGAAACATAGGCTGGGCGCGGTGGCTCACACCTGTAATCCCTACACT >29303_29303_6_FANCA-CYP20A1_FANCA_chr16_89880927_ENST00000568369_CYP20A1_chr2_204143295_ENST00000356079_length(amino acids)=330AA_BP=94 MSDSWVPNSASGQDPGGRRRAWAELLAGRVKREKYNPERAQKLKESAVRLLRSHQDLNALLLEVEGPLCKKLSLSKVIDCDSSEAYANHS SSFIALMQLESVLRNIIKERKGRNFSQHIFIDSLVQGNLNDQQILEDSMIFSLASCIITAKLCTWAICFLTTSEEVQKKLYEEINQVFGN GPVTPEKIEQLRYCQHVLCETVRTAKLTPVSAQLQDIEGKIDRFIIPRETLVLYALGVVLQDPNTWPSPHKFDPDRFDDELVMKTFSSLG -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for FANCA-CYP20A1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for FANCA-CYP20A1 |
![]() (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for FANCA-CYP20A1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | FANCA | C3469521 | FANCONI ANEMIA, COMPLEMENTATION GROUP A (disorder) | 19 | CLINGEN;GENOMICS_ENGLAND;UNIPROT |
Hgene | FANCA | C1856796 | Estren-Dameshek Variant of Fanconi Anemia | 6 | CLINGEN |
Hgene | FANCA | C1856797 | Estren-Dameshek Variant of Fanconi Pancytopenia | 6 | CLINGEN |
Hgene | FANCA | C0015625 | Fanconi Anemia | 5 | CTD_human;GENOMICS_ENGLAND |
Hgene | FANCA | C0030312 | Pancytopenia | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C1384666 | hearing impairment | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C1855710 | Bone marrow hypocellularity | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C2750866 | Growth retardation, pre- and postnatal | 2 | GENOMICS_ENGLAND |
Hgene | FANCA | C0005684 | Malignant neoplasm of urinary bladder | 1 | CTD_human |
Hgene | FANCA | C0005695 | Bladder Neoplasm | 1 | CTD_human |
Hgene | FANCA | C0010606 | Adenoid Cystic Carcinoma | 1 | CTD_human |
Hgene | FANCA | C0020459 | Hyperinsulinism | 1 | CTD_human |
Hgene | FANCA | C0023418 | leukemia | 1 | CGI;GENOMICS_ENGLAND |
Hgene | FANCA | C0023465 | Acute monocytic leukemia | 1 | GENOMICS_ENGLAND |
Hgene | FANCA | C0023467 | Leukemia, Myelocytic, Acute | 1 | CGI;GENOMICS_ENGLAND |
Hgene | FANCA | C0036095 | Salivary Gland Neoplasms | 1 | CTD_human |
Hgene | FANCA | C0220636 | Malignant neoplasm of salivary gland | 1 | CTD_human |
Hgene | FANCA | C0265219 | Miller Dieker syndrome | 1 | GENOMICS_ENGLAND |
Hgene | FANCA | C1257963 | Endogenous Hyperinsulinism | 1 | CTD_human |
Hgene | FANCA | C1257964 | Exogenous Hyperinsulinism | 1 | CTD_human |
Hgene | FANCA | C1257965 | Compensatory Hyperinsulinemia | 1 | CTD_human |
Hgene | FANCA | C3463824 | MYELODYSPLASTIC SYNDROME | 1 | GENOMICS_ENGLAND |
Hgene | FANCA | C4228778 | Abnormality of radial ray | 1 | GENOMICS_ENGLAND |